Approval · Notice of Compliance 1748 · 2001
OMNICEF: Notice of Compliance 1748
Issued November 19, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1748
- Date
- November 19, 2001
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage regimen
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMNICEF | Not yet assigned | — |
Medicinal ingredients
- CEFDINIR 125 MG per 5ML